UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Lisbon, Portugal.
Portuguese Association for CDG, Lisbon, Portugal.
J Inherit Metab Dis. 2017 Sep;40(5):657-672. doi: 10.1007/s10545-017-0066-y. Epub 2017 Jul 19.
Congenital disorders of glycosylation (CDG) are inborn errors of metabolism due to protein and lipid hypoglycosylation. This rapidly growing family of genetic diseases comprises 103 CDG types, with a broad phenotypic diversity ranging from mild to severe poly-organ -system dysfunction. This literature review summarizes cardiac involvement, reported in 20% of CDG. CDG with cardiac involvement were divided according to the associated type of glycosylation: N-glycosylation, O-glycosylation, dolichol synthesis, glycosylphosphatidylinositol (GPI)-anchor biosynthesis, COG complex, V-ATPase complex, and other glycosylation pathways. The aim of this review was to document and interpret the incidence of heart disease in CDG patients. Heart disorders were grouped into cardiomyopathies, structural defects, and arrhythmogenic disorders. This work may contribute to improved early management of cardiac complications in CDG.
先天性糖基化障碍(CDG)是由于蛋白质和脂质低糖化引起的先天性代谢缺陷。这个快速发展的遗传疾病家族包括 103 种 CDG 类型,其表型多样性广泛,从轻到重的多器官-系统功能障碍不等。本文综述总结了 20%的 CDG 患者中报告的心脏受累情况。根据相关的糖基化类型,将伴有心脏受累的 CDG 进行了分类:N-糖基化、O-糖基化、多萜醇合成、糖基磷脂酰肌醇(GPI)-锚生物合成、COG 复合物、V-ATP 酶复合物和其他糖基化途径。本综述的目的是记录和解释 CDG 患者心脏病的发病率。心脏疾病分为心肌病、结构缺陷和心律失常性疾病。这项工作可能有助于改善 CDG 患者心脏并发症的早期管理。